Hermann Heimpel
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.
Journal: Cytometry. Part B, Clinical cytometry
Published: May 20, 2016
Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations.
Journal: British journal of haematology
Published: February 29, 2016
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Journal: Leukemia
Published: March 25, 2015
Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia.
Journal: Journal of cancer research and clinical oncology
Published: March 19, 2014
Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
Journal: Cytometry. Part B, Clinical cytometry
Published: February 24, 2014
Towards the harmonization of result presentation for the eosin-5'- maleimide (EMA) binding test in the diagnosis of hereditary spherocytosis.
Journal: Cytometry. Part B, Clinical cytometry
Published: February 24, 2014
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 04, 2013
Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.
Journal: Blood
Published: August 14, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026